Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. (Q54409186)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

0 references

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

J L Anderson

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

D S Baim

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

S A Fein

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

R A Goldstein

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

T H LeJemtel

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

M J Likoff

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

language of work or name

0 references

publication date

1 April 1987

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

711-722

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasodilator therapy of heart failure. Has the promissory note been paid?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dobutamine: A New Synthetic Cardioactive Sympathetic Amine

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Drugs five years later. Dobutamine

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to dobutamine after a 72 hour continuous infusion

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute dose range study of milrinone in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrophysiologic effects of milrinone in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of patients with severe congestive heart failure treated with oral milrinone

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(87)80223-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(87)80223-1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3549837

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54409186&oldid=1517773433"